01.01.2015 | Research paper
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
Erschienen in: Hormones | Ausgabe 1/2015
Einloggen, um Zugang zu erhalten